Related Experiment Videos
Managing oncology research protocols
1Saint Louis University Hospital, MO.
Abstract:
Oncology research protocol management is important for the effective execution of clinical trials with oncology patients. Clinical trials explore investigational drug safety, efficacy, and effectiveness. Investigational drugs have not received approval for widespread use and marketing by the Food and Drug Administration (FDA). The National Cancer Institute (NCI) has several branches concerned with investigational drug procurement, distribution, and recordkeeping of investigational cancer chemotherapy agents. Before an investigational drug is approved by the FDA for marketing in the United States, it must undergo several phases of pre-clinical and clinical trials. The Institutional Review Board (IRB) must review and approve clinical trials to ensure that studies meet legal, ethical, and scientific standards. The principal investigator (PI) takes responsibility for the clinical trial. Informed consent must be obtained from subjects before they may participate in clinical trials. The informed consent form is reviewed by the IRB. The investigational drug storage, accountability, ordering, distribution, and drug information dissemination process is improved with a pharmacy-coordinated investigational drug service.
Insights
Effective oncology clinical trial management relies on robust investigational drug protocols. A pharmacy-coordinated service enhances drug handling, safety, and trial execution for cancer patients.
Area of Science:
- Oncology
- Clinical Pharmacology
- Drug Development
Background:
- Clinical trials are crucial for evaluating investigational cancer drugs before Food and Drug Administration (FDA) approval.
- Effective management of oncology research protocols ensures patient safety and data integrity.
- The National Cancer Institute (NCI) oversees aspects of investigational cancer drug procurement and distribution.
Purpose of the Study:
- To highlight the importance of investigational drug management in oncology clinical trials.
- To emphasize the role of pharmacy-coordinated services in optimizing investigational drug handling.
- To underscore the necessity of regulatory and ethical oversight in clinical research.
Main Methods:
- Review of standard procedures for investigational drug management in oncology research.
- Examination of regulatory requirements including FDA and Institutional Review Board (IRB) approvals.
- Analysis of the components of a pharmacy-coordinated investigational drug service.
Main Results:
- Pharmacy coordination improves investigational drug storage, accountability, ordering, and distribution.
- Adherence to protocols ensures compliance with legal, ethical, and scientific standards.
- Streamlined processes enhance the safety, efficacy, and effectiveness evaluation of investigational drugs.
Conclusions:
- A pharmacy-coordinated investigational drug service is vital for successful oncology clinical trials.
- Robust protocol management is essential for the ethical and scientific execution of cancer research.
- Optimized drug handling contributes to the reliable assessment of new cancer therapies.